1. Home
  2. BLRX vs JYD Comparison

BLRX vs JYD Comparison

Compare BLRX & JYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • JYD
  • Stock Information
  • Founded
  • BLRX 2003
  • JYD 2001
  • Country
  • BLRX Israel
  • JYD China
  • Employees
  • BLRX N/A
  • JYD N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • JYD Oil Refining/Marketing
  • Sector
  • BLRX Health Care
  • JYD Consumer Discretionary
  • Exchange
  • BLRX Nasdaq
  • JYD Nasdaq
  • Market Cap
  • BLRX 17.0M
  • JYD 17.8M
  • IPO Year
  • BLRX 2011
  • JYD 2023
  • Fundamental
  • Price
  • BLRX $3.67
  • JYD $0.17
  • Analyst Decision
  • BLRX Strong Buy
  • JYD
  • Analyst Count
  • BLRX 2
  • JYD 0
  • Target Price
  • BLRX $19.00
  • JYD N/A
  • AVG Volume (30 Days)
  • BLRX 32.7K
  • JYD 610.0K
  • Earning Date
  • BLRX 08-14-2025
  • JYD 10-24-2025
  • Dividend Yield
  • BLRX N/A
  • JYD N/A
  • EPS Growth
  • BLRX N/A
  • JYD N/A
  • EPS
  • BLRX N/A
  • JYD N/A
  • Revenue
  • BLRX $17,251,000.00
  • JYD $77,444,271.00
  • Revenue This Year
  • BLRX N/A
  • JYD N/A
  • Revenue Next Year
  • BLRX N/A
  • JYD N/A
  • P/E Ratio
  • BLRX N/A
  • JYD N/A
  • Revenue Growth
  • BLRX 1.19
  • JYD 13.54
  • 52 Week Low
  • BLRX $2.30
  • JYD $0.09
  • 52 Week High
  • BLRX $26.80
  • JYD $8.00
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 44.89
  • JYD 41.05
  • Support Level
  • BLRX $3.42
  • JYD $0.15
  • Resistance Level
  • BLRX $3.79
  • JYD $0.18
  • Average True Range (ATR)
  • BLRX 0.25
  • JYD 0.01
  • MACD
  • BLRX 0.02
  • JYD -0.00
  • Stochastic Oscillator
  • BLRX 47.17
  • JYD 50.43

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About JYD Jayud Global Logistics Limited

Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, supply chain management, and other value-added services.

Share on Social Networks: